Duk-Woo Park, MD

Quick facts

Marketed products

• Conventional antithrombotic strategy · Cardiovascular
  Conventional antithrombotic strategy prevents blood clot formation through antiplatelet and/or anticoagulant agents to reduce thrombotic events.
• P-CAB 50
• Tailored antithrombotic strategy · Cardiovascular
  A personalized anticoagulation approach that tailors antithrombotic therapy selection and dosing based on individual patient characteristics, biomarkers, and clinical risk factors.

Phase 2 pipeline

• Ultimaster™ Tansei™ stents

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Duk-Woo Park, MD portfolio CI brief
• Duk-Woo Park, MD pipeline updates RSS